Soluble P‑selectin promotes acute myocardial infarction onset but not severity

Guo,Ling; Sun,Guizhi; Wang,Guoyu; Ning,Wenhu; Zhao,Kan

doi:10.3892/mmr.2014.2917

Soluble P‑selectin promotes acute myocardial infarction onset but not severity

Authors:
- Ling Guo
- Guizhi Sun
- Guoyu Wang
- Wenhu Ning
- Kan Zhao
View Affiliations

Affiliations: Department of Cardiology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Pharmacy, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Emergency, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China
Published online on: November 10, 2014 https://doi.org/10.3892/mmr.2014.2917
Pages: 2027-2033

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

P‑selectin, an integral membrane glycoprotein of platelets and endothelial cells, and the soluble form of P‑selectin are hypothesized to play a role in the initiation of atherosclerosis and acute myocardial infarction (AMI). However, limited data are available with which to evaluate the main role of soluble P‑selectin (sP‑selectin) in the onset or the severity of AMI. In the present study, we investigated 15 patients who suffered from angina, 10 patients who underwent percutaneous coronary intervention (PCI) therapy and 10 patients who underwent thrombolysis therapy, compared with 15 volunteers with no cardiovascular disease. We confirmed that the plasma sP‑selectin levels were increased in patients with obesity (particularly pericardial obesity) and hyperlipidemia, positively correlated with plasma tumor necrosis factor (TNF)‑α and strongly negatively correlated with adiponectin in all patients regardless of AMI status. Furthermore, sP‑selectin levels were significantly higher in PCI and thrombolysis patients compared with angina patients and the control cohort. However, we observed that sP‑selectin levels did not change following PCI and thrombolysis therapy. In addition, there was no correlation between sP‑selectin levels and the severity of AMI in the cohort which received PCI or thrombolysis therapy. Therefore, we deduced that sP‑selectin only induced the onset of AMI but did not promote its severity. To confirm this hypothesis, a P‑selectin inhibitor was administered to an atherosclerosis formation model, plaque rapture model and neointimal hyperplasia model. We revealed that atherosclerotic plaque formation and rupture, neointimal formation and neointimal bleeding were suppressed by the sP‑selectin inhibitor. We concluded that sP‑selectin, induced by systemic inflammation in conditions including obesity and hyperlipidemia, promoted atherosclerotic plaque and neointimal formation, plaque rapture and neointimal bleeding, further leading to AMI. We also demonstrated that sP‑selectin had no effect on the severity of AMI.

View Figures

View References

1	Geng JG, Chen M and Chou KC: P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis. Curr Med Chem. 11:2153–2160. 2004. View Article : Google Scholar : PubMed/NCBI
2	Polek A, Sobiczewski W and Matowicka-Karna J: P-selectin and its role in some diseases. Postepy Hig Med Dosw (Online). 63:465–470. 2009.
3	Yang J, Furie BC and Furie B: The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost. 81:1–7. 1999.PubMed/NCBI
4	Blann AD, Nadar SK and Lip GY: The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J. 24:2166–2179. 2003. View Article : Google Scholar : PubMed/NCBI
5	Ramacciotti E, Blackburn S, Hawley AE, et al: Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis. Clin Appl Thromb Hemost. 17:425–431. 2011. View Article : Google Scholar : PubMed/NCBI
6	Woollard KJ and Chin-Dusting J: P-selectin antagonism in inflammatory disease. Curr Pharm Des. 16:4113–4118. 2010. View Article : Google Scholar
7	Burke AP and Virmani R: Pathophysiology of acute myocardial infarction. Med Clin North Am. 91:553–572. 2007. View Article : Google Scholar : PubMed/NCBI
8	Woollard KJ and Chin-Dusting J: Therapeutic targeting of p-selectin in atherosclerosis. Inflamm Allergy Drug Targets. 6:69–74. 2007. View Article : Google Scholar : PubMed/NCBI
9	Aversano T, Aversano LT, Passamani E, et al: Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA. 287:1943–1951. 2002. View Article : Google Scholar : PubMed/NCBI
10	Ferroni P, Basili S, Martini F, et al: Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J Investig Med. 48:21–27. 2000.PubMed/NCBI
11	Ertenli I, Kiraz S, Arici M, et al: P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis. J Rheumatol. 25:1054–1058. 1998.PubMed/NCBI
12	Tamagawa-Mineoka R, Katoh N, Ueda E, Masuda K and Kishimoto S: Platelet-derived microparticles and soluble P-selectin as platelet activation markers in patients with atopic dermatitis. Clin Immunol. 131:495–500. 2009. View Article : Google Scholar : PubMed/NCBI
13	Konishi M, Sugiyama S, Sugamura K, et al: Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease. Atherosclerosis. 209:573–578. 2010. View Article : Google Scholar
14	Zhou J, Lhotak S, Hilditch BA and Austin RC: Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation. 111:1814–1821. 2005. View Article : Google Scholar : PubMed/NCBI
15	Johnson JL and Jackson CL: Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis. 154:399–406. 2001. View Article : Google Scholar : PubMed/NCBI
16	Sata M, Maejima Y, Adachi F, et al: A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol. 32:2097–2104. 2000. View Article : Google Scholar : PubMed/NCBI
17	Phillips JW, Barringhaus KG, Sanders JM, et al: Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation. 107:2244–2249. 2003. View Article : Google Scholar : PubMed/NCBI
18	Lin WY, Lee LT, Chen CY, et al: Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord. 26:1232–1238. 2002. View Article : Google Scholar : PubMed/NCBI
19	Guo L, Ning W, Tan Z, Gong Z and Li X: Mechanism of matrix metalloproteinase axis-induced neointimal growth. J Mol Cell Cardiol. 66:116–125. 2013. View Article : Google Scholar : PubMed/NCBI
20	Konishi M, Sugiyama S, Sato Y, et al: Pericardial fat inflammation correlates with coronary artery disease. Atherosclerosis. 213:649–655. 2010. View Article : Google Scholar : PubMed/NCBI
21	Hamminga EA, van der Lely AJ, Neumann HA and Thio HB: Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses. 67:768–773. 2006. View Article : Google Scholar : PubMed/NCBI
22	Hackam DG and Anand SS: Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 290:932–940. 2003. View Article : Google Scholar : PubMed/NCBI
23	Quarck R, De Geest B, Stengel D, et al: Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice. Circulation. 103:2495–2500. 2001. View Article : Google Scholar : PubMed/NCBI
24	Merten M and Thiagarajan P: P-selectin in arterial thrombosis. Z Kardiol. 93:855–863. 2004. View Article : Google Scholar : PubMed/NCBI
25	Hong MK, Mintz GS, Lee CW, et al: Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation. 110:928–933. 2004. View Article : Google Scholar : PubMed/NCBI
26	Lee SG, Lee CW, Hong MK, Kim JJ, Park SW and Park SJ: Change of multiple complex coronary plaques in patients with acute myocardial infarction: a study with coronary angiography. Am Heart J. 147:281–286. 2004. View Article : Google Scholar : PubMed/NCBI
27	Finn AV, Nakano M, Narula J, Kolodgie FD and Virmani R: Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol. 30:1282–1292. 2010. View Article : Google Scholar : PubMed/NCBI
28	Claeys MJ, Bosmans J, Veenstra L, Jorens P, De Raedt H and Vrints CJ: Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation. 99:1972–1977. 1999. View Article : Google Scholar : PubMed/NCBI
29	Triant VA, Lee H, Hadigan C and Grinspoon SK: Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 92:2506–2512. 2007. View Article : Google Scholar : PubMed/NCBI
30	Rosengren A, Wallentin L, Simoons M, et al: Cardiovascular risk factors and clinical presentation in acute coronary syndromes. Heart. 91:1141–1147. 2005. View Article : Google Scholar : PubMed/NCBI
31	Kvasnicka T, Kvasnicka J, Ceska R, Grauova B and Vrablik M: Increasing plasma levels of soluble cell adhesion molecules (sE-selectin, sP-selectin and sICAM-1) in overweight adults with combined hyperlipidemia. Sb Lek. 102:473–477. 2001.
32	De Pergola G, Pannacciulli N, Coviello M, et al: sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors. Nutr Metab Cardiovasc Dis. 18:227–232. 2008. View Article : Google Scholar
33	Larsson PT, Hallerstam S, Rosfors S and Wallen NH: Circulating markers of inflammation are related to carotid artery atherosclerosis. Int Angiol. 24:43–51. 2005.PubMed/NCBI
34	Yngen M, Ostenson CG, Hu H, Li N, Hjemdahl P and Wallen NH: Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation. Diabetologia. 47:537–540. 2004. View Article : Google Scholar : PubMed/NCBI
35	Gokulakrishnan K, Deepa R, Mohan V and Gross MD: Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome - the Chennai Urban Rural Epidemiology Study. Metabolism. 55:237–242. 2006. View Article : Google Scholar : PubMed/NCBI
36	Xu DY, Zhao SP and Peng WP: Elevated plasma levels of soluble P-selectin in patients with acute myocardial infarction and unstable angina. An inverse link to lipoprotein(a). Int J Cardiol. 64:253–258. 1998. View Article : Google Scholar : PubMed/NCBI
37	Atalar E, Aytemir K, Haznedaroglu I, et al: Increased plasma levels of soluble selectins in patients with unstable angina. Int J Cardiol. 78:69–73. 2001. View Article : Google Scholar : PubMed/NCBI
38	Eberini I, Gianazza E, Breghi L, et al: Apolipoprotein A-I breakdown is induced by thrombolysis in coronary patients. Ann Med. 39:306–311. 2007. View Article : Google Scholar : PubMed/NCBI